Use of a transient assay for studying the genetic determinants of Fv1 restriction.
about
Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteinsAbsence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndromeAntimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cellsTrim5alpha protein restricts both HIV-1 and murine leukemia virusThe human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activitiesRetrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alphaIndependent evolution of an antiviral TRIMCyp in rhesus macaquesAll three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restrictionDynamics and restriction of murine leukemia virus cores in mitotic and interphase cellsNovel Escape Mutants Suggest an Extensive TRIM5α Binding Site Spanning the Entire Outer Surface of the Murine Leukemia Virus Capsid ProteinA unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsidStructural basis of lentiviral subversion of a cellular protein degradation pathwayLv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to IntegrationPseudotype-based neutralization assays for influenza: a systematic analysis.Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.Proteasomal degradation of TRIM5alpha during retrovirus restrictionIdentification of the regions of Fv1 necessary for murine leukemia virus restriction.SUMO-interacting motifs of human TRIM5α are important for antiviral activityHuman tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.Capsid processing requirements for abrogation of Fv1 and Ref1 restrictionClonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed.Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.Restriction of lentivirus in monkeysHare TRIM5α restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genesThe N-terminus of murine leukaemia virus p12 protein is required for mature core stability.Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1Postentry restriction of Mason-Pfizer monkey virus in mouse cellsEvolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.A conserved mechanism of retrovirus restriction in mammals.Identification of a genomic reservoir for new TRIM genes in primate genomes.A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoatingBinding of more than one Tva800 molecule is required for ASLV-A entry.The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.Phospho-dependent Regulation of SAMHD1 Oligomerisation Couples Catalysis and Restriction.
P2860
Q21131588-3B011A9C-8F1F-4DB2-846B-3C09A64616E5Q21245047-65A41F3F-DBFA-4B97-BB72-BAB629716A93Q24533368-94D926E6-B2E3-48F3-9FC1-80390484EB00Q24536359-8D8D3A31-9229-479F-83A0-474C8D1E0575Q24561922-FC4CF758-82E8-4122-BA65-8ABCA9B6E685Q24561930-4FA117D2-7F61-451D-BAF9-1ED8EF2BDB2DQ24561939-582A80FD-D7A6-478C-9C4B-9B562D952326Q24656091-F53771F0-0637-485C-8CFA-BC202313DB07Q24673961-63BC394E-6F05-4D7C-8085-0CE2C49083EDQ27303013-C567DBD6-8C16-4DB5-90EF-92F233855E01Q27667494-5A2B5169-F39F-4250-BFB1-B6DEC4982FA5Q27678148-3FD6F229-C59C-4D2B-9B56-A0D346D7A7ABQ27680878-E7CE24BE-6750-41F2-A7FA-FBB9302B90DDQ28546614-2335663B-42BB-4C5C-862B-A63260353C6CQ30374662-34A31F6B-B8F8-4339-BBE4-0588D1FE0A48Q30499709-71E89D48-CD27-4290-9D77-DE7E9EBA0A18Q33312857-55B9B81B-F2BB-48B6-B710-DB36AA554724Q33337129-ACA743C6-3249-48F1-A3CB-EA794578FCCDQ33851839-C967B0A0-7477-496F-8BB6-7ED5532231C7Q33872238-6AE3D1C5-C380-44F6-A32B-7702D2223754Q33883891-06BE4766-ECD5-43EC-9DBA-02883EFA2739Q33912010-1647695C-C4B4-4F10-B516-D809FA23D32CQ33993393-2A6A75BD-23F8-4B8F-A9E9-699086EAFEB0Q34120302-94A5E027-9409-48A6-829E-36A677E51F21Q34154725-069FC259-CEF7-4E6D-A431-E8F371B3A7DEQ34291026-70F64BB6-14B5-4741-B690-8F0846C839A0Q34428741-53A26E52-3A84-4232-8BC6-6444B7ADCDCBQ34545869-A759C26C-64AF-4883-96D3-9F7405A090AFQ35023942-3E4ABF91-27A3-472F-A395-0D6EF2829F15Q35076669-ECADEEAE-C685-4253-875D-919953C9054DQ35112900-0C61C0EB-81F7-4FB0-B7F6-D36F73F5EEFFQ35140352-8F1A2D19-AC14-4F60-B62C-122DCEAB07ECQ35191091-D63E2813-7A48-4470-9385-B252B90F702EQ35422974-18955AEC-4C24-4EB8-B2F8-1B1EAFAFC2FBQ35586967-A2FA44B4-6FC3-4C90-8678-F3D68ECC20FCQ35641044-B15852DE-CDFD-4B13-9C3E-E50265B6059CQ35689590-CBE7B46C-3CAA-4900-89C4-CB22AE29AA58Q35705083-880ADF53-2FD8-4354-B20A-A51A362ABEA5Q35784739-D8693321-65FF-4F14-BD3B-31DE087BA3FDQ35796953-6E863C10-B1CD-4F6A-904C-7AF3FA7EABBE
P2860
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
@ast
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
@en
type
label
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
@ast
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
@en
prefLabel
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
@ast
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
@en
P2093
P2860
P1433
P1476
Use of a transient assay for studying the genetic determinants of Fv1 restriction.
@en
P2093
P2860
P304
P356
10.1128/JVI.74.16.7422-7430.2000
P577
2000-08-01T00:00:00Z